Elizabeth Hollingsworth
Family Medicine · Decatur, INNPI 1437508124
Payments from drug & device makers
Across 224 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$622
- Bayer$607
- Axsome Therapeutics, Inc.$596
- AstraZeneca$584
- GSK$503
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,802100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $1,217 |
| Novo Nordisk | 38 | $622 |
| Bayer | 14 | $607 |
| Axsome Therapeutics, Inc. | 12 | $596 |
| AstraZeneca | 13 | $584 |
| GSK | 13 | $503 |
| Amgen | 8 | $352 |
| Sanofi-aventis U.S. LLC | 5 | $264 |
| Lilly USA, LLC | 8 | $213 |
| Teva Pharmaceuticals USA, Inc. | 2 | $134 |
| Idorsia Pharmaceuticals US Inc | 1 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $94 |
| Esperion Therapeutics, Inc. | 4 | $79 |
| Pfizer | 5 | $66 |
| Exact Sciences | 2 | $56 |
| Astellas Pharma US Inc | 2 | $51 |
| Boehringer Ingelheim | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Eisai Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $23 |
| Merck | 2 | $23 |
| Mylan Specialty L.p. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,802 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 324 | $383,678 |
| JardianceEmpagliflozin | 216 | $286,929 |
| MounjaroTirzepatide | 115 | $136,049 |
| KerendiaFinerenone | 64 | $85,655 |
| JanuviaSitagliptin Phosphate | 43 | $61,985 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $56,351 |
| EliquisApixaban | 46 | $56,304 |
| FarxigaDapagliflozin Propanediol | 40 | $54,968 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 41 | $44,720 |
| TrulicityDulaglutide | 26 | $39,482 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 14 | $36,349 |
| RybelsusSemaglutide | 14 | $31,729 |
| Bydureon BciseExenatide Microspheres | 14 | $10,826 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $10,372 |
| VascepaIcosapent Ethyl | 11 | $8,106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus | $622 | $451,757352 claims |
| Boehringer IngelheimJardiance | $28 | $286,929216 claims |
| Lilly USA, LLCMounjaro, Trulicity | $213 | $175,532141 claims |
| BayerKerendia | $607 | $85,65564 claims |
| MerckJanuvia, Janumet Xr | $23 | $72,35755 claims |
| GSKTrelegy Ellipta | $503 | $56,35173 claims |
| PfizerEliquis | $66 | $56,30446 claims |
| AstraZenecaFarxiga | $584 | $54,96840 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $264 | $44,72041 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Decatur
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.